XXL GENES
DEAD

Serial Number

78342258

Owner

Geneart AG

Attorney

Phil Makrogiannis

Filing Date

Dec 17, 2003

Add to watchlist:

No watchlists yet
View on USPTO

XXL GENES Trademark

Serial Number: 78342258 • Registration: 3040072

XXL GENES is a trademark filed by Geneart AG on December 17, 2003. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Geneart AG (7 trademarks)

Josef-Engert-Str. 11
Regensburg 93053 , DE

Entity Type: 03

Geneart GmbH (5 trademarks)

Josef-Engert-Str. 9
D-93053 Regensburg , DE

Entity Type: 03

THERMO FISHER SCIENTIFIC GENEART GMBH (4 trademarks)

SANTA CLARA, CA 95051

Entity Type: 16

Trademark Details

Filing Date

December 17, 2003

Registration Date

January 10, 2006

Published for Opposition

October 18, 2005

Cancellation Date

August 12, 2016

Goods & Services

Automatic machines for the synthesis of deoxyribonucleic acids; robotic machines for laboratory purposes, namely, pippetting robots, liquid handling robots, DNA synthesizer robots; computer terminals; computer programs for use as tools in the field of biotechnology and molecular biology; computer software to increase potency of enzymes and enzyme preparations, bacteria preparations, bacteriological preparations, micro-organism cultures, biological preparations, diagnostic preparations; computer operating programs; computer peripherals; computer keyboards; blank magnetic data carriers; blank optical disks; data processors; computer memories; blank floppy disks; hard drives for computers; printers for use with computers; computer interface boards; laptop computers; data processors, namely, readers and scanners; computer mouse; semiconductors; computer modems; computer monitors; computer hardware; and notebook computers

[ Medicines for human medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; bacteriological preparations for medical and veterinary purposes, for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis, as well as for use in gene therapy; biological preparations for medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; germicides for medical and institutional use, and domestic uses; vermicides for medical and institutional use, domestic use, and residential uses, fungicides for medical and institutional use, and domestic uses; biological preparations for medical diagnostic laboratory use, namely, proteins, DNA, RNA and modifications thereof; and diagnostic materials for clinical and medical laboratory purposes, namely, proteins, DNA, RNA and modifications thereof ]

[ Bacteria for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; bacteriological preparations for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; micro-organism cultures for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biological preparations for clinical, research and medical laboratory use, namely, proteins, DNA, RNA and modifications thereof; diagnostic preparations for clinical, research and medical laboratory use, namely, proteins, DNA, RNA and modifications thereof; and enzymes and enzyme preparations for use in the field of food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds ]

Computer services, namely, updating of computer software for others, consultation in the fields of biotechnology, designing computer software for others, maintenance of computer software for others, leasing of computer software, providing an online computer database in the fields of medicines, pharmaceuticals, and genomics, computer programming for others, leasing of computers, and recovery of computer data for others; chemical analysis for others; research for others in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; laboratory research services for others in the fields of of bacteriology and chemistry; consultation in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering and machine engineering; pharmaceutical consultation; measuring calibration for others; development and research of new products for others; technical consultation in the field of environmental protection; technical project planning and consulting services in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; and quality control for others

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Aug 12, 2016 CAEX
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 2, 2016 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 23, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 23, 2014 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 3, 2013 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 3, 2013 C15P
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 21, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 21, 2011 REAP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Sep 13, 2011 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 19, 2011 APRE
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 2, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 2, 2011 REAP
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jul 11, 2011 815F
TEAS SECTION 8 & 15 RECEIVED
Jul 11, 2011 E815
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 11, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 11, 2011 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2011 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 9, 2006 TCCA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 13, 2006 ASGN
REGISTERED-PRINCIPAL REGISTER
Jan 10, 2006 R.PR
PUBLISHED FOR OPPOSITION
Oct 18, 2005 PUBO
NOTICE OF PUBLICATION
Sep 28, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 7, 2005 PREV
ASSIGNED TO LIE
Jul 1, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2005 CNSA
AMENDMENT FROM APPLICANT ENTERED
Jun 18, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 10, 2005 CRFA
PAPER RECEIVED
Jun 10, 2005 MAIL
CONTINUATION OF FINAL REFUSAL E-MAILED
May 16, 2005 GNCF
ACTION CONTINUING A FINAL - COMPLETED
May 16, 2005 CNCF
AMENDMENT FROM APPLICANT ENTERED
May 5, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2005 CRFA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 16, 2005 ZZZX
WITHDRAWN BEFORE PUBLICATION
Apr 4, 2005 CWBP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 5, 2005 PREV
ASSIGNED TO LIE
Feb 4, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 13, 2005 CNSA
AMENDMENT FROM APPLICANT ENTERED
Jan 11, 2005 ACEC
PAPER RECEIVED
Dec 13, 2004 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2004 CRFA
PAPER RECEIVED
Dec 10, 2004 MAIL
FINAL REFUSAL E-MAILED
Dec 5, 2004 GNFR
FINAL REFUSAL WRITTEN
Dec 5, 2004 CNFR
AMENDMENT FROM APPLICANT ENTERED
Dec 4, 2004 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 15, 2004 CRFA
PAPER RECEIVED
Nov 15, 2004 MAIL
NON-FINAL ACTION MAILED
Aug 5, 2004 CNRT
ASSIGNED TO EXAMINER
Jul 13, 2004 DOCK
NEW APPLICATION ENTERED
Jan 7, 2004 NWAP